1. Kim HY, Cho EJ, Chun S, Kim KH, Cho D. Red blood cell alloimmunization in Korean patients with myelodysplastic syndrome and liver cirrhosis. Ann Lab Med. 2019; 39:218–222. PMID:
30430787.
2. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013; 122:1062–1071. PMID:
23723452.
3. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012; 120:528–537. PMID:
22563085.
4. Moreira Júnior G, Bordin JO, Kuroda A, Kerbauy J. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol. 1996; 52:197–200. PMID:
8756087.
5. Samarah F, Srour MA, Yaseen D, Dumaidi K. Frequency of red blood cell alloimmunization in patients with sickle cell disease in Palestine. Adv Hematol. 2018; 2018:5356245. PMID:
29977298.
6. DeanL. Blood groups and red cell antigens. Bethesda: National Center for Biotechnology Information;2005. p. 32. p. 50. p. 57. p. 63. p. 69. p. 81.
7. Chou ST, Flanagan JM, Vege S, Luban NLC, Brown RC, Ware RE, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv. 2017; 1:1414–1422. PMID:
29296782.
8. Chou ST, Evans P, Vege S, Coleman SL, Friedman DF, Keller M, et al.
RH genotype matching for transfusion support in sickle cell disease. Blood. 2018; 132:1198–1207. PMID:
30026182.